相关实验视频
Updated: Jan 8, 2026

08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
1.2K
赫普西丁通过调节p53/miR-34a/Trem2轴来抑制骨质细胞分化,以缓解骨质疏松症
Lujun Chen1, Guiwen Liu2, Sheng Liu3
1Department of Pediatrics, The First Affiliated Hospital of Gannan Medical University, Ganzhou City, Jiangxi Province, 341000, China.
Experimental gerontology
|December 12, 2025
概括
肝素是铁的关键调节剂,通过抑制骨质细胞分化来缓解骨质疏松症. 这通过p53/miR-34a/Trem2通路发生,为骨质疏松症治疗提供了潜在的治疗策略.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 铁的新陈代谢 铁的新陈代谢
背景情况:
- 骨质疏松症 (OP) 的进展与铁的积累有关.
- 肝素对铁平衡至关重要,可能为OP提供治疗益处.
- 在OP中肝素的精确分子机制在很大程度上是未知的.
研究的目的:
- 为了研究肝素在骨质疏松症中的作用.
- 阐明在OP中由肝素调节的分子途径.
- 确定肝素,p53,miR-34a和Trem2在骨代谢中的关系.
主要方法:
- 构建了转基因小鼠 (肝素和Trem2过度表达) 和使用卵巢切除术 (OVX) 模型.
- 通过微CT和染色来评估骨的微观结构,质量和骨质细胞活动.
- 通过细胞培养,西斑和qPCR分析骨质细胞分化,基因表达 (miR-34a,Trem2) 和蛋白质水平 (p53,Trem2).
- 使用ChIP,双化酶和RIP试验证实了分子相互作用.
主要成果:
- 肝素过度表达减弱了OVX小鼠的骨质疏松症进展,并抑制了骨质细胞形成.
- 赫普西丁激活了p53,促进了miR-34a的转录,该转录的目标是Trem2.
- 抑制miR-34a可以逆转hepcidin对骨质细胞的抑制作用.
- 2过度表达加剧了骨损失,这种效应在生态模型中被废除了.
结论:
- 赫普西丁通过抑制骨质细胞分化来缓解骨质疏松症的进展.
- p53/miR-34a/Trem2轴是肝素对骨影响的关键调节途径.
- 研究结果表明,肝素是骨质疏松症的潜在治疗点.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Hormones and Bone Tissue
3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Dipeptidyl Peptidase 4 Inhibitors
557
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
557
